Insider Selling: David Walt Unloads 5,000 Shares of Illumina Stock (ILMN)
Illumina (NASDAQ:ILMN) Director David Walt sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 18th. The stock was sold at an average price of $83.11, for a total value of $415,550.00. Following the completion of the sale, the director now directly owns 926,488 shares of the company’s stock, valued at approximately $77,000,418. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
A number of research firms have recently commented on ILMN. Analysts at Wells Fargo & Co. initiated coverage on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Monday, September 9th. They set an “outperform” rating on the stock. Separately, analysts at Bank of America Corp. set a $90.00 price target on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Thursday, August 22nd. They now have a “buy” rating on the stock. Finally, analysts at Janney Montgomery Scott initiated coverage on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Thursday, August 15th. They set a “neutral” rating on the stock.
One analyst has rated the stock with a sell rating, eight have given a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $73.81.
Shares of Illumina (NASDAQ:ILMN) traded down 0.89% on Friday, hitting $80.94. The stock had a trading volume of 1,309,252 shares. Illumina has a 52 week low of $44.78 and a 52 week high of $85.81. The stock has a 50-day moving average of $79.63 and a 200-day moving average of $69.37. The company has a market cap of $10.127 billion and a P/E ratio of 96.08.
Illumina (NASDAQ:ILMN) last released its earnings data on Tuesday, July 23rd. The company reported $0.43 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.40 by $0.03. The company had revenue of $346.09 million for the quarter, compared to the consensus estimate of $331.77 million. During the same quarter in the prior year, the company posted $0.40 earnings per share. The company’s quarterly revenue was up 23.3% on a year-over-year basis. Analysts expect that Illumina will post $1.72 EPS for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.